{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:29:48Z","timestamp":1793168988609,"version":"4.5.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T00:00:00Z","timestamp":1312416000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002171","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T16:37:19Z","timestamp":1312475839000},"page":"e1002171","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["IL-10 Blocks the Development of Resistance to Re-Infection with Schistosoma mansoni"],"prefix":"10.1371","volume":"7","author":[{"given":"Mark S.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W.","family":"Cheever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.","volume":"6","author":"P Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1371\/journal.pntd.0000207","article-title":"The schistosomiasis research agenda\u2013what now?","volume":"2","author":"JM Bethony","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1371\/journal.pntd.0000032","article-title":"A schistosomiasis research agenda.","volume":"1","author":"DG Colley","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S003118200999093X","article-title":"Schistosomiasis--a rich vein of research.","volume":"136","author":"P Hagan","year":"2009","journal-title":"Parasitology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.pt.2008.05.006","article-title":"Will new antischistosomal drugs finally emerge?","volume":"24","author":"D Cioli","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00436-009-1546-2","article-title":"Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.","volume":"105","author":"RA Abdul-Ghani","year":"2009","journal-title":"Parasitol Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.","volume":"3","author":"SD Melman","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.","volume":"21","author":"MJ Doenhoff","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/14760584.7.6.745","article-title":"Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.","volume":"7","author":"PJ Hotez","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.actatropica.2008.05.023","article-title":"Recent advances in vaccine research against schistosomiasis in Brazil.","volume":"108","author":"SC Oliveira","year":"2008","journal-title":"Acta Trop"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0001-706X(03)00062-7","article-title":"Progress towards a vaccine for schistosomiasis.","volume":"86","author":"EJ Pearce","year":"2003","journal-title":"Acta Trop"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actatropica.2005.08.005","article-title":"Development of a vaccine against Schistosoma japonicum in China: a review.","volume":"96","author":"ZD Wu","year":"2005","journal-title":"Acta Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02761998000100021","article-title":"Resistance to infection\/reinfection by Schistosoma mansoni is not augmented by three treatments with 45 days intervals.","volume":"93","author":"AM Silveira","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0169-4758(94)90226-7","article-title":"Human resistance to Schistosoma infections: age or experience?","volume":"10","author":"B Gryseels","year":"1994","journal-title":"Parasitol Today"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1086\/517456","article-title":"Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.","volume":"178","author":"F Mutapi","year":"1998","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4269\/ajtmh.1995.52.549","article-title":"Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.","volume":"52","author":"JF Etard","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0035-9203(85)90391-8","article-title":"Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.","volume":"79","author":"AE Butterworth","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(02)09781-7","article-title":"Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study.","volume":"360","author":"DM Karanja","year":"2002","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/429668","article-title":"Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.","volume":"191","author":"M Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/422604","article-title":"Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.","volume":"190","author":"S Joseph","year":"2004","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.","volume":"441","author":"E Bettelli","year":"2006","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","article-title":"Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.","volume":"25","author":"M Kamanaka","year":"2006","journal-title":"Immunity"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI31546","article-title":"IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice.","volume":"117","author":"MS Wilson","year":"2007","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/intimm\/11.11.1811","article-title":"Development of an assay to measure in vivo cytokine production in the mouse.","volume":"11","author":"FD Finkelman","year":"1999","journal-title":"Int Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00927527","article-title":"Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro.","volume":"63","author":"B Becker","year":"1980","journal-title":"Z Parasitenkd"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0001-706X(00)00076-0","article-title":"Tegumental changes in adult Schistosoma mansoni harboured in mice treated with praziquantel enantiomers.","volume":"76","author":"X Shuhua","year":"2000","journal-title":"Acta Trop"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0035-9203(87)90360-9","article-title":"Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.","volume":"81","author":"MJ Doenhoff","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl","key":"ref28","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1017\/S003118200007534X","article-title":"Immune-dependent chemotherapy of schistosomiasis.","volume":"105","author":"PG Fallon","year":"1992","journal-title":"Parasitology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jn\/136.1.183","article-title":"Nutritional status improves after treatment of schistosoma japonicum-infected children and adolescents.","volume":"136","author":"HM Coutinho","year":"2006","journal-title":"J Nutr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0035-9203(86)90268-3","article-title":"Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment.","volume":"80","author":"DG Colley","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/eji.1830260628","article-title":"Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection.","volume":"26","author":"JL Grogan","year":"1996","journal-title":"Eur J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.170.1.470","article-title":"Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis.","volume":"170","author":"AC La Flamme","year":"2003","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00034983.1975.11687009","article-title":"Failure to immunise mice against Schistosoma mansoni by therapeutic eradication of the adult worm burden.","volume":"69","author":"D Gold","year":"1975","journal-title":"Ann Trop Med Parasitol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0035-9203(87)90248-3","article-title":"Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.","volume":"81","author":"RF Sturrock","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-4758(97)01168-X","article-title":"Puberty and Age-related Changes in Susceptibility to Schistosome Infection.","volume":"14","author":"AJ Fulford","year":"1998","journal-title":"Parasitol Today"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/504326","article-title":"Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum.","volume":"42","author":"JD Kurtis","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1371\/journal.pntd.0000637","article-title":"Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.","volume":"4","author":"CL Black","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0035-9203(91)90231-M","article-title":"Eosinophilia and eosinophil helminthotoxicity in patients treated for Schistosoma mansoni infections.","volume":"85","author":"G Kimani","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Pt 6","key":"ref39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/icb.1990.51","article-title":"Attempts to induce resistance in mice to Schistosoma japonicum and Schistosoma mansoni by exposure to crude schistosome antigens plus cloned glutathione-S-transferases.","volume":"68","author":"GF Mitchell","year":"1990","journal-title":"Immunol Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/15169","article-title":"Seeking the ghost of worms past.","volume":"5","author":"ME Woolhouse","year":"1999","journal-title":"Nat Med"},{"issue":"Pt 1","key":"ref41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0031182000053476","article-title":"The relationship between pathology and resistance to reinfection with Schistosoma mansoni in mice: a causal mechanism of resistance in chronic infections.","volume":"94","author":"SM McHugh","year":"1987","journal-title":"Parasitology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/344352","article-title":"Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses.","volume":"186","author":"AH van den Biggelaar","year":"2002","journal-title":"J Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/IAI.74.1.370-381.2006","article-title":"T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.","volume":"74","author":"T Leenstra","year":"2006","journal-title":"Infect Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actatropica.2008.05.027","article-title":"Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.","volume":"108","author":"IR Caldas","year":"2008","journal-title":"Acta Trop"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2334-7-139","article-title":"Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age.","volume":"7","author":"F Mutapi","year":"2007","journal-title":"BMC Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.4049\/jimmunol.147.8.2713","article-title":"Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection.","volume":"147","author":"A Sher","year":"1991","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.4049\/jimmunol.151.6.3192","article-title":"Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo.","volume":"151","author":"PO Flores Villanueva","year":"1993","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.4049\/jimmunol.156.9.3315","article-title":"Recombinant IL-10 and IL-10\/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis.","volume":"156","author":"PO Flores-Villanueva","year":"1996","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-3024.1997.d01-224.x","article-title":"IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA\/J mice infected with Schistosoma mansoni.","volume":"19","author":"SC Bosshardt","year":"1997","journal-title":"Parasite Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.4049\/jimmunol.159.10.5014","article-title":"Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo.","volume":"159","author":"TA Wynn","year":"1997","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4049\/jimmunol.160.9.4473","article-title":"IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease.","volume":"160","author":"TA Wynn","year":"1998","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.164.12.6406","article-title":"IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis.","volume":"164","author":"KF Hoffmann","year":"2000","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.4049\/jimmunol.172.5.3157","article-title":"The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.","volume":"172","author":"M Hesse","year":"2004","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.173.10.6346","article-title":"Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.","volume":"173","author":"NE Mangan","year":"2004","journal-title":"J Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.174.4.1962","article-title":"CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.","volume":"174","author":"CM Freeman","year":"2005","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/eji.200323501","article-title":"IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni.","volume":"33","author":"CH Sadler","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.4049\/jimmunol.181.10.7214","article-title":"IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.","volume":"181","author":"DR Herbert","year":"2008","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1086\/314748","article-title":"Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens.","volume":"179","author":"SM Montenegro","year":"1999","journal-title":"J Infect Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-3024.1998.00166.x","article-title":"Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation.","volume":"20","author":"PL Falcao","year":"1998","journal-title":"Parasite Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0100-879X1998000100024","article-title":"Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection.","volume":"31","author":"R Correa-Oliveira","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-3083.1997.d01-136.x","article-title":"Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses.","volume":"46","author":"LC Malaquias","year":"1997","journal-title":"Scand J Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4049\/jimmunol.163.2.927","article-title":"Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.","volume":"163","author":"KF Hoffmann","year":"1999","journal-title":"J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/intimm\/dxg142","article-title":"IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine.","volume":"15","author":"KG Hogg","year":"2003","journal-title":"Int Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4049\/jimmunol.180.6.4090","article-title":"IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL\/6 mice.","volume":"180","author":"CF Anderson","year":"2008","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.","volume":"194","author":"Y Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.","volume":"420","author":"Y Belkaid","year":"2002","journal-title":"Nature"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e1000004","DOI":"10.1371\/journal.ppat.1000004","article-title":"IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.","volume":"4","author":"KN Couper","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaci.2009.05.002","article-title":"Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain.","volume":"124","author":"L Bin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.20071948","article-title":"IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.","volume":"205","author":"DG Brooks","year":"2008","journal-title":"J Exp Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform.","volume":"207","author":"PA Darrah","year":"2010","journal-title":"J Exp Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.4049\/jimmunol.164.8.4212","article-title":"Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development.","volume":"164","author":"JU Igietseme","year":"2000","journal-title":"J Immunol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/IAI.73.11.7620-7628.2005","article-title":"Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection.","volume":"73","author":"MT Roberts","year":"2005","journal-title":"Infect Immun"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.167.3.1535","article-title":"Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination.","volume":"167","author":"RA Silva","year":"2001","journal-title":"J Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/intimm\/dxq001","article-title":"GITR engagement preferentially enhances proliferation of functionally competent D4+CD25+FoxP3+ regulatory T cells.","volume":"22","author":"G Liao","year":"2010","journal-title":"Int Immunol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1465-9921-10-93","article-title":"GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma.","volume":"10","author":"AC Motta","year":"2009","journal-title":"Respir Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0169-4758(90)90414-Y","article-title":"Leaky livers, portal shunting and immunity to schistosomes.","volume":"6","author":"RA Wilson","year":"1990","journal-title":"Parasitol Today"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1128\/IAI.61.12.4984-4993.1993","article-title":"Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.","volume":"61","author":"M Roberts","year":"1993","journal-title":"Infect Immun"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0035-9203(84)90190-1","article-title":"Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.","volume":"78","author":"AE Butterworth","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1128\/IAI.74.4.2169-2176.2006","article-title":"Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.","volume":"74","author":"LM Ganley-Leal","year":"2006","journal-title":"Infect Immun"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4269\/ajtmh.2006.75.1053","article-title":"Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni.","volume":"75","author":"LM Ganley-Leal","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/349243a0","article-title":"Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.","volume":"349","author":"P Hagan","year":"1991","journal-title":"Nature"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/eji.1830220622","article-title":"Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.","volume":"22","author":"DW Dunne","year":"1992","journal-title":"Eur J Immunol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.2000.62.57","article-title":"Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment.","volume":"62","author":"IR Caldas","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-3024.1997.d01-186.x","article-title":"The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection.","volume":"19","author":"DW Dunne","year":"1997","journal-title":"Parasite Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/168.4.1000","article-title":"Resistance to Schistosoma mansoni in humans: influence of the IgE\/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.","volume":"168","author":"CE Demeure","year":"1993","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"ref86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0074-02761992000800014","article-title":"Human IgE responses to Schistosoma mansoni and resistance to reinfection.","volume":"87","author":"DW Dunne","year":"1992","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/595792","article-title":"Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.","volume":"199","author":"PN Mwinzi","year":"2009","journal-title":"J Infect Dis"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:51:16Z","timestamp":1712663476000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002171"}},"subtitle":[],"editor":[{"given":"Edward J.","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,4]]},"references-count":87,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002171","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12774956.14048054","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,4]]}}}